These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25443902)

  • 1. Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result.
    Shi Y; Fung KZ; Freedland SJ; Hoffman RM; Tang VL; Walter LC
    Urology; 2014 Nov; 84(5):1058-65. PubMed ID: 25443902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.
    Espaldon R; Kirby KA; Fung KZ; Hoffman RM; Powell AA; Freedland SJ; Walter LC
    Urology; 2014 Mar; 83(3):599-605. PubMed ID: 24439009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of statin medications on prostate-specific antigen levels.
    Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year downstream outcomes following prostate-specific antigen screening in older men.
    Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
    JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
    Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
    JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.
    Fowke JH; Motley SS; Barocas DA; Cookson MS; Concepcion R; Byerly S; Smith JA
    Cancer Causes Control; 2011 Mar; 22(3):417-26. PubMed ID: 21170754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Screening for Prostate Cancer Among Men Who Use Statins.
    Vettenranta A; Murtola TJ; Raitanen J; Raittinen P; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
    JAMA Oncol; 2022 Jan; 8(1):61-68. PubMed ID: 34817559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.
    Mondul AM; Selvin E; De Marzo AM; Freedland SJ; Platz EA
    Cancer Causes Control; 2010 May; 21(5):671-8. PubMed ID: 20072809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
    Freedland SJ; Hamilton RJ; Gerber L; Banez LL; Moreira DM; Andriole GL; Rittmaster RS
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):254-9. PubMed ID: 23567655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
    Hamilton RJ; Banez LL; Aronson WJ; Terris MK; Platz EA; Kane CJ; Presti JC; Amling CL; Freedland SJ
    Cancer; 2010 Jul; 116(14):3389-98. PubMed ID: 20586112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations among statins, preventive care, and prostate cancer mortality.
    Kumar A; Riviere P; Luterstein E; Nalawade V; Vitzthum L; Sarkar RR; Bryant AK; Einck JP; Mundt AJ; Murphy JD; Rose BS
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):475-485. PubMed ID: 32029930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer.
    Song C; Park S; Park J; Shim M; Kim A; Jeong IG; Hong JH; Kim CS; Ahn H
    Prostate; 2015 Feb; 75(2):211-7. PubMed ID: 25327522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
    Sarkar RR; Parsons JK; Bryant AK; Ryan ST; Kader AK; McKay RR; D'Amico AV; Nguyen PL; Hulley BJ; Einck JP; Mundt AJ; Kane CJ; Murphy JD; Rose BS
    JAMA Intern Med; 2019 Jun; 179(6):812-819. PubMed ID: 31058923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White men.
    Lee KM; Bryant AK; Lynch JA; Robison B; Alba PR; Agiri FY; Pridgen KM; DuVall SL; Yamoah K; Garraway IP; Rose BS
    Cancer; 2024 Jan; 130(2):224-231. PubMed ID: 37927109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
    Catalona WJ; Partin AW; Slawin KM; Brawer MK; Flanigan RC; Patel A; Richie JP; deKernion JB; Walsh PC; Scardino PT; Lange PH; Subong EN; Parson RE; Gasior GH; Loveland KG; Southwick PC
    JAMA; 1998 May; 279(19):1542-7. PubMed ID: 9605898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
    Chun FK; Hutterer GC; Perrotte P; Gallina A; Valiquette L; Benard F; McCormack M; Briganti A; Ionescu C; Jeldres C; Guay JP; Saad F; Karakiewicz PI
    BJU Int; 2007 Jul; 100(1):37-41. PubMed ID: 17488305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer screening by prostate-specific antigen (PSA); a relevant approach for the small population of the Cayman Islands.
    Jyoti SK; Blacke C; Patil P; Amblihalli VP; Nicholson A
    Cancer Causes Control; 2018 Jan; 29(1):87-92. PubMed ID: 28918559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: a simulation study.
    Mondul AM; Caffo B; Platz EA
    Cancer Epidemiol; 2011 Aug; 35(4):e6-11. PubMed ID: 21167804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between statin use and the diagnosis of prostate cancer in a population based cohort.
    Breau RH; Karnes RJ; Jacobson DJ; McGree ME; Jacobsen SJ; Nehra A; Lieber MM; St Sauver JL
    J Urol; 2010 Aug; 184(2):494-9. PubMed ID: 20620405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.